These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17855626

  • 1. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
    Bassing CH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW.
    Blood; 2008 Feb 15; 111(4):2163-9. PubMed ID: 17855626
    [Abstract] [Full Text] [Related]

  • 2. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
    Yin B, Yang-Iott KS, Chao LH, Bassing CH.
    Blood; 2011 Jan 06; 117(1):175-85. PubMed ID: 20947684
    [Abstract] [Full Text] [Related]

  • 3. Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.
    Yin B, Lee BS, Yang-Iott KS, Sleckman BP, Bassing CH.
    J Immunol; 2012 Aug 01; 189(3):1372-9. PubMed ID: 22730535
    [Abstract] [Full Text] [Related]

  • 4. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
    Deriano L, Chaumeil J, Coussens M, Multani A, Chou Y, Alekseyenko AV, Chang S, Skok JA, Roth DB.
    Nature; 2011 Mar 03; 471(7336):119-23. PubMed ID: 21368836
    [Abstract] [Full Text] [Related]

  • 5. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
    Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C, Alt FW.
    Cell; 2003 Aug 08; 114(3):359-70. PubMed ID: 12914700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.
    Zha S, Bassing CH, Sanda T, Brush JW, Patel H, Goff PH, Murphy MM, Tepsuporn S, Gatti RA, Look AT, Alt FW.
    J Exp Med; 2010 Jul 05; 207(7):1369-80. PubMed ID: 20566716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
    Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W, Van Dyke T.
    Mol Cell Biol; 1998 Jun 05; 18(6):3495-501. PubMed ID: 9584189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
    Rowh MA, DeMicco A, Horowitz JE, Yin B, Yang-Iott KS, Fusello AM, Hobeika E, Reth M, Bassing CH.
    Oncogene; 2011 Nov 24; 30(47):4757-64. PubMed ID: 21625223
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.
    Dujka ME, Puebla-Osorio N, Tavana O, Sang M, Zhu C.
    Oncogene; 2010 Feb 18; 29(7):957-65. PubMed ID: 19915617
    [Abstract] [Full Text] [Related]

  • 17. Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development.
    Liu X, Jiang W, Dubois RL, Yamamoto K, Wolner Z, Zha S.
    Proc Natl Acad Sci U S A; 2012 Mar 06; 109(10):3903-8. PubMed ID: 22355127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
    Fusello A, Horowitz J, Yang-Iott K, Brady BL, Yin B, Rowh MA, Rappaport E, Bassing CH.
    Cell Cycle; 2013 Sep 01; 12(17):2867-75. PubMed ID: 23966158
    [Abstract] [Full Text] [Related]

  • 20. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK, Weaver Z, Barlow C, Shen R, Eckhaus M, Steinberg SM, Ried T, Wynshaw-Boris A, Hodes RJ.
    Proc Natl Acad Sci U S A; 2000 Jun 06; 97(12):6664-9. PubMed ID: 10841564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.